M D 3 3 Pill - white oval, 19mm
Pill with imprint M D 3 3 is White, Oval and has been identified as Doxycycline Hyclate Delayed-Release 150 mg. It is supplied by Mylan Pharmaceuticals Inc.
Doxycycline is used in the treatment of Acne; Amebiasis; Actinomycosis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M D 3 3
Doxycycline Hyclate Delayed-Release
- Imprint
- M D 3 3
- Strength
- 150 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-3030 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
hypromellose phthalate,
lactose monohydrate,
povidone,
corn starch,
sodium chloride,
sodium lauryl sulfate,
stearic acid,
magnesium silicate,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "M D 3 3"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,621)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
- Doxycycline drug information
- Doxycycline (Oral) (Advanced Reading)
- Doxycycline Capsules (Rosacea)
- Doxycycline Delayed-Release Tablets
- Doxycycline Injection
Other brands
Vibramycin, Monodox, Oracea, Doryx, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (EENT) (AHFS Monograph)
- Doxycycline Calcium (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Oracea, Doryx, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
